OptoDrum system to measure visual function in mice
Official title: OptoDrum for In Vivo Visual Function Testing
Funded at York College · NIH-11361724 · Data updated 2026-11-12
A new instrument will be bought to measure how well mice see and tell colors, with automated tracking to reduce stress and bias.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | York College NIH-funded |
| Lab location | 1 site (Jamaica, United States) |
| Project start | July 1, 2026 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $56,402 |
| NIH project number | 1S10GM164676-01 |
| Project ID | NIH-11361724 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable (animal model study)
✕Less likely to help
No direct patient participation expected since the work uses mice.
What this research studies
This grant funds purchase of the Striatech OptoDrum to non-invasively measure visual acuity and contrast sensitivity in mice using head-free, automated tracking. It will strengthen a mouse study on mitochondrial-targeted neuroprotection after optic nerve injury by linking visual function with brain and cellular changes. The equipment will enhance hands-on neuroscience training for undergraduate students and broaden collaborative, translational neuroscience work within York College and the surrounding academic community.
Why it matters
Potential benefit: It could advance understanding of retinal nerve injuries and improve training and collaboration in neuroscience at York College.
How similar studies have gone: Previous studies using automated optomotor systems have successfully linked structure, molecules, and function in vision research.
Where this research is happening
-
York College
Jamaica, United States Active
Researchers
- Principal investigator: Macneil, Margaret — York College
- Study coordinator: Macneil, Margaret
Related research
Other NIH-funded projects on the same topics.
-
Protecting the eye's nerve cells that transmit vision
Researchers will test whether a mitochondrial-targeting peptide called HDAP2 can help protect retinal ganglion cells after optic nerve injury, with the goal of helping people with glaucoma, diabetic retinopathy, or optic nerve trauma.
-
Protecting retinal nerve cells from damage.
This study is looking at a way to help protect important eye cells from damage caused by conditions like glaucoma and diabetes, using a special compound called HDAP2 that boosts cell energy, and it's being tested in mice to see how well it works.
-
Exploring the brain's sensory circuits in monkeys
This study is looking at how the monkey brain processes sensory information by using special imaging techniques to see the tiny details of brain circuits, which could help us understand sensory disorders better.
-
Understanding how a specific protein contributes to a serious condition related to inflammation.
This study is looking at how a protein called serum amyloid A (SAA) changes in people with AA amyloidosis, a serious condition linked to long-term inflammation, to better understand how it causes damage and to help find new ways to treat it.
-
Understanding how age, health conditions, and genetics affect cannabis use in older adults
This study is looking at how aging, health issues, and genetics affect how safe and helpful cannabis is for older adults, so we can better understand its risks and benefits for their health.
-
How biological sex and anxiety affect learning to overcome fear
This study is looking at how being male or female, feeling anxious, and how well you handle uncertainty can affect your ability to overcome fears, with the goal of making anxiety treatments even better for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.